Effect of erythrophagocytosis-induced ferroptosis during angiogenesis in atherosclerotic plaques
Authors:
- Pauline PuylaertPPPauline Puylaert
- Lynn RothLRLynn Roth
- Melissa Van PraetMPMelissa Van Praet
- Isabel PintelonIPIsabel Pintelon
- Catalina DumitrascuCDCatalina Dumitrascu
- Alexander van NuijsAlexander van Nuijs
- Greta KlejborowskaGKGreta Klejborowska
- Pieter-Jan GunsPGPieter-Jan Guns
- Tom Vanden BergheTBTom Vanden Berghe
- Koen AugustynsKAKoen Augustyns
- Guido R. Y. De MeyerGMGuido R. Y. De Meyer
- Wim MartinetWMWim Martinet
Open Access
- 29 April 2023
- journal article
- research article
- Published by Springer Nature in Angiogenesis
- Vol. 26 (4) , 505-522
Abstract
Intraplaque (IP) angiogenesis is a key feature of advanced atherosclerotic plaques. Because IP vessels are fragile and leaky, erythrocytes are released and phagocytosed by macrophages (erythrophagocytosis), which leads to high intracellular iron content, lipid peroxidation and cell death. In vitro experiments showed that erythrophagocytosis by macrophages induced non-canonical ferroptosis, an emerging type of regulated necrosis that may contribute to plaque destabilization. Erythrophagocytosis-induced ferroptosis was accompanied by increased expression of heme-oxygenase 1 and ferritin, and could be blocked by co-treatment with third generation ferroptosis inhibitor UAMC-3203. Both heme-oxygenase 1 and ferritin were also expressed in erythrocyte-rich regions of carotid plaques from ApoE−/−Fbn1C1039G+/− mice, a model of advanced atherosclerosis with IP angiogenesis. The effect of UAMC-3203 (12.35 mg/kg/day) on atherosclerosis was evaluated in ApoE−/−Fbn1C1039G+/− mice fed a western-type diet (WD) for 12 weeks (n = 13 mice/group) or 20 weeks (n = 16–21 mice/group) to distinguish between plaques without and with established IP angiogenesis, respectively. A significant decrease in carotid plaque thickness was observed after 20 weeks WD (87 ± 19 μm vs. 166 ± 20 μm, p = 0.006), particularly in plaques with confirmed IP angiogenesis or hemorrhage (108 ± 35 μm vs. 322 ± 40 μm, p = 0.004). This effect was accompanied by decreased IP heme-oxygenase 1 and ferritin expression. UAMC-3203 did not affect carotid plaques after 12 weeks WD or plaques in the aorta, which typically do not develop IP angiogenesis. Altogether, erythrophagocytosis-induced ferroptosis during IP angiogenesis leads to larger atherosclerotic plaques, an effect that can be prevented by ferroptosis inhibitor UAMC-3203.Keywords
Funding Information
- Fund for Scientific Research (FWO)-Flanders (EOS 30826052, G026723N)
This publication has 38 references indexed in Scilit:
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Intraplaque Hemorrhage: An Imaging Marker for Atherosclerotic Plaque Destabilization?Arteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Intraplaque haemorrhages as the trigger of plaque vulnerabilityEuropean Heart Journal, 2011
- Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stabilityCardiovascular Research, 2007
- Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic PlaquesCirculation, 2005
- Secretion of Ferritin by Iron-laden Macrophages and Influence of LipoproteinsFree Radical Research, 2004
- Intraplaque Hemorrhage and Progression of Coronary AtheromaNew England Journal of Medicine, 2003
- Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Platelet Phagocytosis and Processing of β-Amyloid Precursor Protein as a Mechanism of Macrophage Activation in AtherosclerosisCirculation Research, 2002
- Quantification of Adherent and Nonadherent Cells Cultured in 96-Well Plates Using the Supravital Stain Neutral RedAnalytical Biochemistry, 1993